CCN2 Is Required for the TGF-β Induced Activation of Smad1 - Erk1/2 Signaling Network by Nakerakanti, Sashidhar S. et al.
CCN2 Is Required for the TGF-b Induced Activation of
Smad1 - Erk1/2 Signaling Network
Sashidhar S. Nakerakanti, Andreea M. Bujor, Maria Trojanowska*
The Arthritis Center, Boston University School of Medicine, Boston, Massachusetts, United States of America
Abstract
Connective tissue growth factor (CCN2) is a multifunctional matricellular protein, which is frequently overexpressed during
organ fibrosis. CCN2 is a mediator of the pro-fibrotic effects of TGF-b in cultured cells, but the specific function of CCN2 in
the fibrotic process has not been elucidated. In this study we characterized the CCN2-dependent signaling pathways that
are required for the TGF-b induced fibrogenic response. By depleting endogenous CCN2 we show that CCN2 is
indispensable for the TGF-b-induced phosphorylation of Smad1 and Erk1/2, but it is unnecessary for the activation of
Smad3. TGF-b stimulation triggered formation of the CCN2/b3 integrin protein complexes and activation of Src signaling.
Furthermore, we demonstrated that signaling through the avb3 integrin receptor and Src was required for the TGF-b
induced Smad1 phosphorylation. Recombinant CCN2 activated Src and Erk1/2 signaling, and induced phosphorylation of
Fli1, but was unable to stimulate Smad1 or Smad3 phosphorylation. Additional experiments were performed to investigate
the role of CCN2 in collagen production. Consistent with the previous studies, blockade of CCN2 abrogated TGF-b-induced
collagen mRNA and protein levels. Recombinant CCN2 potently stimulated collagen mRNA levels and upregulated activity
of the COL1A2 promoter, however CCN2 was a weak inducer of collagen protein levels. CCN2 stimulation of collagen was
dose-dependent with the lower doses (,50 ng/ml) having a stimulatory effect and higher doses having an inhibitory effect
on collagen gene expression. In conclusion, our study defines a novel CCN2/avb3 integrin/Src/Smad1 axis that contributes to
the pro-fibrotic TGF-b signaling and suggests that blockade of this pathway may be beneficial for the treatment of fibrosis.
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Introduction
TGF-b is a multifunctional polypeptide growth factor that
regulates cell proliferation, functional differentiation, extracellular
matrix (ECM) production, cell motility, and apoptosis [1].
Canonical TGF-b signaling is initiated by ligand binding to a
heteromeric complex of transmembrane serine/threonine kinases,
type I (ALK5) and type II, and subsequent activation of
transcriptional co-regulators, Smad2 and Smad3 [1]. In addition,
several recent studies have shown that TGF-b can also activate
Smad1/5 signaling [2,3,4]. In endothelial cells, this mode of
signaling involves ALK5 and ALK1 receptors, and also depends
on an accessory receptor, endoglin [3,5]. However in other cell
types including various epithelial cell lines, Smad1/5 is phosphor-
ylated by ALK5 receptor independently of BMP receptors [4,6].
Besides activation of Smad pathways, TGF-b induces numerous
other signaling molecules, including MAP kinases, PI3 kinase/Akt,
and Rho-like GTPase [7,8]. Deregulated TGF-b signaling has
been implicated in various pathological conditions, including
fibrosis and cancer.
Connective Tissue Growth Factor (CTGF, CCN2) is a member
of the CCN family of matricellular proteins, which play important
roles in a variety of cellular processes, including angiogenesis,
chondrogenesis, and wound healing [9]. CCN2 expression is also
frequently deregulated during pathological conditions such as
fibrosis and cancer [10,11]. In particular, overexpression of CCN2
has been demonstrated in a number of fibrotic diseases occurring
in different organs, strongly suggesting an important role for this
growth factor in the process of excessive matrix deposition [12].
Transgenic mice overexpressing CCN2 in fibroblasts developed
fibrosis in multiple organs [13], whereas mice lacking fibroblast
expression of CCN2 were protected from the bleomycin-induced
dermal fibrosis [14]. Recent genetic evidence further supports a
role for CCN2 in fibrosis [15,16]. Consistent with this view, it has
been shown that CCN2 synthesis is induced by TGF-b and that it
is required for the TGF-b induction of collagen [17]. Specific
mechanisms involved in the CCN2-dependent fibrogenic response
have not been elucidated. In general, the intracellular signaling
elicited by the members of the CCN family, including CCN2,
remains elusive, because the bona fide CCN receptor has not been
identified. However, it has been well documented that CCN2
interacts with various integrin receptors in a cell-type dependent
manner. For example, adhesion of CCN2 to the a6b1 integrin
receptor and heparan sulphate proteoglycan leads to activation of
ERK1/2 and upregulation of MMP1 in fibroblasts, [18], while in
endothelial cells CCN2 promotes angiogenic responses through
binding to the avb3 integrin [19]. Similarly, avb3 integrin is
required for the CCN2 induced migration of mesangial cells [20].
Furthermore, activation of Erk1/2, PKB, and Src and upregula-
tion of fibronectin by CCN2 is also dependent on b3 integrin in
mesangial cells [20]. Other signaling molecules, which were shown
to be activated in mesangial cells by CCN2 include JNK,
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has been reported that CCN2 signals through neurotrophin
receptor TrkA, suggesting an ability to cross-activate receptors
with a tyrosine kinase activity (RTK) [21], but so far this
observation has not been extended to other RTKs. It has also been
suggested that CCN2 exerts its biological effects through
modulating the activity of other growth factors. For example,
Abreu et al have shown that CCN2 binds to TGF-b resulting in
increased ligand receptor binding, whereas CCN2 binding to
BMP4 interferes with the BMP4 receptor binding [22]. Despite
the progress in identifying signaling pathways elicited by CCN2,
the specific requirement for CCN2 in the TGF-b-dependent up-
regulation of collagen genes remains unexplained.
Because CCN2 is considered a key mediator of the fibrogenic
effects of TGF-b and is viewed as a potential target for the anti-
fibrotic therapies, we wished to gain additional insights into the
molecular mechanisms governing the fibrogenic activity of CCN2.
Here we show that CCN2 is required for the TGF-b induced
phosphorylation of Smad1, Erk1/2 and Fli1, while it is dispensable
for the activation of Smad3 signaling. These effects of CCN2 are
mediated through the avb3 integrin receptor and also involve
activation of nonreceptor tyrosine kinase Src. However, in the
absence of TGF-b, CCN2 is not able to activate Smad1 signaling
and is only a weak inducer of collagen protein in dermal
fibroblasts.
Results
CCN2 mediates TGF-b induced collagen expression
In the first set of experiments, we established an experimental
model to investigate the role of CCN2 in TGF-b signaling. In
agreement with previous studies using different cell types
[23,24,25,26], in foreskin fibroblasts TGF-b induction of CCN2
mRNA and protein preceded that of collagen, whereas up-
regulation of collagen persisted for a longer time (data not shown).
To study the role of CCN2 in the TGF-b induced up-regulation of
collagen, endogenous CCN2 was knocked down using adenoviral
CCN2 siRNA. Transduction with CCN2 siRNA virus efficiently
suppressed the endogenous levels of CCN2 by more than 80%
both at the mRNA and protein level (Fig. 1A-B). Consistent with
previous reports, depletion of CCN2 almost completely abrogated
TGF-b induced up-regulation of collagen synthesis (Fig. 1C-D).
Furthermore, transcriptional activation of COL1A2 promoter by
TGF-b was inhibited in the absence of CCN2 (Fig. 1E). These
results are in agreement with the previously published reports that
implicated CCN2 in the TGF-b induced collagen gene expression
[17,27,28,29].
CCN2 is required for the TGF-b induced activation of the
Smad1 pathway
We next sought to determine the role of CCN2 in mediating
TGF-b induction of collagen. Previous studies have shown that in
addition to the classical Smad3 pathway, the non-Smad3 pathways
such as MAP Kinase, as well as Smad1 play a role in the TGF-b
regulation of collagen gene expression [3]. We first determined the
kinetics of the activation of Smad1, Smad2, Smad3, and Erk1/2
pathways in response to TGF-b stimulation. TGF-b induced rapid
phosphorylation of Smad1, Smad2, Smad3 and Erk1/2 proteins
within 30 minutes post stimulation (Fig. 2A). Activation of Smad1
and Erk1/2 pathways was sustained up to 48 hours, while
activation of Smad2 and Smad3 was more transient and was not
detectable after 24 hours. We have also observed an increase in
Smad1 protein levels starting at 12 hours post stimulation. We
next investigated whether CCN2 contributes to activation of the
above signaling molecules. CCN2 was depleted from the cells
using adenoviral siRNA prior to stimulation with TGF-b.A s
shown in Fig. 2B, phosphorylation of Smad1 in response to TGF-b
was almost completely abolished in the absence of CCN2. Up-
regulation of total Smad1 protein levels was also abrogated.
Likewise, TGF-b induced phosphorylation of Erk1/2 was
significantly decreased (Fig. 2B and Fig. S1A). On the other
hand, depletion of CCN2 had no appreciable effect on the TGF-b
induced Smad3 phosphorylation (Fig. 2C and Fig. S1B), in
agreement with the recently reported observations by Quan et al
(2011) [30]. We concluded from these experiments that CCN2 is
required for the TGF-b-induced Smad1 and Erk1/2 phosphor-
ylation.
CCN2/avb3 integrin signaling contributes to the TGF-b
dependent activation of the Smad1 pathway
Previous reports have demonstrated that CCN2 signals via
integrin receptors and heparan sulfate proteoglycan (HSPG). We
focused on the avb3 integrin, which was shown to cluster with the
TGF-bRII and to mediate TGF-b induced proliferation in lung
fibroblasts [31]. Importantly, avb3 integrin was also shown to
mediate the profibrotic effects of TGF-b in scleroderma fibroblasts
[32]. We used immunofluorescence to examine the distribution of
CCN2 and avb3 integrin in response to TGF-b. In unstimulated
cells, CCN2 and avb3 integrin were diffusely distributed in the
cytoplasm (Fig. 3A), while after 30 minutes of treatment with
TGF-b, co-localization of CCN2 with avb3 integrin was observed.
To further verify these findings we used co-immunoprecipitation.
As shown in Fig. 3B formation of CCN2 complexes with b3
integrin was observed in cells stimulated for 30 min. with TGF-b,
but was not detectable in unstimulated fibroblasts. To determine
whether avb3 integrin contributes to Smad1 activation in response
to TGF-b, we suppressed the endogenous levels of b3 integrin
.70% using siRNA (Fig. S2A). As shown in Fig. 3C, depletion of
b3 integrin abrogated TGF-b induced phosphorylation of Smad1,
suggesting that avb3 integrin receptor signaling contributes to the
TGF-b mediated activation of Smad1 pathway. We also observed
similar decrease in TGF-b induced phosphorylation of Smad1
when we blocked avb3 integrin function using LM609 antibody
prior to fibroblast stimulation with TGF-b (Fig. S2B). Further-
more, depletion of b3 integrin levels abrogated TGF-b induced
expression of CCN2 and moderately decreased expression of
collagen (Fig. 3D). To investigate whether HSPG is also involved
in activation of Smad1, fibroblasts were treated with Xylosidase to
block HSPG function, prior to stimulation with TGF-b. This
treatment did not affect phosphorylation of Smad1, suggesting that
HSPG is not involved in this process (data not shown).
Src is required for the TGF-b dependent activation of
Smad1 pathway
Src is one of the major nonreceptor tyrosine kinases activated
downstream of both avb3 integrin and TGF-b [33,34]. In addition,
studies by Crean et al (2004) showed that Src is rapidly induced by
CCN2 [20]. To determine if Src is involved in activation of Smad1
signaling, we blocked Src activity using three independent
approaches: knock down by Src siRNA (Fig. S3A), forced
expression of a dominant negative Src, and a specific pharmaco-
logical inhibitor of Src, SU6656 (Fig S3B). Blockade of Src
abrogated TGF-b stimulation of Smad1 phosphorylation (Fig. 4A-
B). Furthermore, blockade of Src attenuated TGF-b induced up-
regulation of CCN2 and collagen (Fig. 4C). Taken together, these
results suggest that TGF-b induced activation of Smad1 and its
target genes requires CCN2, avb3 integrin, and Src.
CCN2 Contributes to Smad1 Phosphorylation
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e21911Figure 1. CCN2 mediates TGF-b induced collagen upregulation. (A, B) Foreskin fibroblasts were transduced with increasing doses of
AdenoCCN2 siRNA virus or the control scramble virus for 72 hours. CCN2 mRNA levels were analyzed by quantitative RT-PCR (A) and the protein
levels by western blot (B). (C,D) Foreskin fibroblasts were transduced with increasing doses of AdenoCCN2 siRNA virus or the control scramble virus
for 72 hours followed by stimulation with TGF-b for 48 hours. Collagen mRNA levels were analyzed by quantitative RT-PCR (C) and collagen protein
levels by western blot (D). (E) Foreskin fibroblasts were transduced with increasing doses of AdenoCCN2 siRNA virus or the control scramble virus for
72 hours followed by transfection with COL1A2 (22 Kb) luciferase promoter plasmid construct. Next day after transfection TGF-b was added for
24 hours and the promoter activity was determined. The values represent mean 6 S.E. of three independent experiments. * & **significant values at
p,0.05 & p,0.001 respectively.
doi:10.1371/journal.pone.0021911.g001
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fibroblasts
Thus far we established that CCN2 is required for the activation
of selected TGF-b induced signaling pathways, including Smad1
and Erk1/2; we next sought to determine whether CCN2 alone is
sufficient to induce these pathways. Treatment of cells with
recombinant human CCN2 (rCCN2) (5–100 ng/ml) for 30 min.
induced phospho-Src in a dose-dependent manner with maximal
stimulation observed at 25 ng/ml and no stimulatory effects at a
higher dose (100 ng/ml), while phospho-Erk1/2 showed a
different pattern with activation at all the doses tested (5–
100 ng/ml. (Fig. 5A). In a time course experiment, rCCN2
(25 ng/ml) rapidly induced phosphorylation of Src (5 min.) with
maximal induction observed at 30 min, while Erk1/2 activation
occurred with delayed kinetics as compared to Src (Fig. 5B). To
determine whether b3 integrin is required for the CCN2
stimulation of p-Src and p-Erk1/2, b3 integrin was knockdown
using siRNA. As shown in Fig 5C, depletion of b3 decreased basal
and CCN2 induced phosphorylation of Src and Erk1/2. In
contrast to Src and Erk1/2, treatment with CCN2 did not
stimulate Smad1 or Smad3 phosphorylation (data not shown),
albeit CCN2 moderately increased total Smad1 levels (Fig. 5D and
Fig. S4). Together, these data suggest that CCN2 via b3 integrin is
sufficient to activate selected TGF-b inducible pathways, including
Src and Erk1/2, however CCN2 alone is not able to activate the
Smad1 pathway.
CCN2 is a moderate inducer of collagen synthesis
To determine whether CCN2 alone is capable to induce
collagen synthesis, we first used CCN2 expressing adenovirus.
Foreskin fibroblasts were infected with increasing doses of virus.
We observed that CCN2 modulates collagen synthesis in a dose-
dependent fashion. Overexpression of CCN2 at moderate levels
resulted in induction of collagen mRNA and protein, while high
levels of CCN2 markedly decreased collagen mRNA and protein
synthesis (Fig. 6A). We next compared side-by-side the effects of
TGF-b and CCN2 on collagen production. By carefully titrating
the dose of adenovirus, CCN2 was expressed at the level observed
Figure 2. CCN2 is required for the TGF-b induced activation of Smad1 and Erk1/2 pathways. (A) Foreskin fibroblasts were stimulated with
TGF-b for the indicated time periods and analyzed for Smad1, Smad3, Smad2 and Erk phosphorylation kinetics. (B,C) Fibroblasts were transduced with
AdenoCCN2 siRNA or the control scrambled virus for 72 h followed by stimulation with TGF-b for the indicated time points. Phosphorylation status
and the total protein levels of Smad1, Erk1/2, and Smad3 were determined by western blot.
doi:10.1371/journal.pone.0021911.g002
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these treatments increased collagen protein production, the
response was more robust in cells stimulated with TGF-b vs cells
overexpressing CCN2, suggesting that CCN2 alone is only a weak
inducer of collagen protein as compared to TGF-b. Additional
experiments were performed using rCCN2. Upregulation of
COL1A1 mRNA level (Fig. 6C) and COL1A2 promoter activity
(Fig. 6D) was comparable between rCCN2 and TGF-b, while
collagen protein was only weakly induced by rCCN2 (Fig. 6E).
These data suggest that CCN2 may be primarily involved in
Figure 3. TGF-b induced Smad1 phosphorylation is mediated through avb3 integrin. (A) Foreskin fibroblasts cultured on cover slips were
stimulated with TGF-b for 30 minutes. The cells were fixed with paraformaldehyde and incubated with CCN2 (green) and avb3 (red) antibodies and
analyzed by Confocal microscopy. (B) Cell lysates from TGF-b stimulated cells were immunoprecipitated with b3 integrin and analyzed for CCN2 by
western blot. (C) Fibroblasts were transfected with b3 siRNA oligos and then stimulated with TGF-b for 30 minutes and analyzed for Smad1
phosphorylation by western blot. (D) Fibroblasts were transfected with b3 siRNA oligos and then stimulated with TGF-b for 24 hours and examined
for CCN2 and Collagen levels.
doi:10.1371/journal.pone.0021911.g003
Figure 4. Src mediates TGF-b induced Smad1 phosphorylation. (A) Foreskin fibroblasts were transfected with control (SCR) or Src siRNA
oligos. pSmad1 and total Smad1 were analyzed by western blot. (B) Foreskin fibroblasts were transduced with dominant negative Src adenovirus and
then stimulated with TGF-b for 30 minutes. pSmad1 and total Smad1 were examined by western blot. (C) Foreskin fibroblasts were transfected with
Src siRNA oligos (top panel) or transduced with dominant negative Src adenovirus (lower panel), then stimulated with TGF-b for 24 hours and
examined for CCN2 and collagen levels by western blot.
doi:10.1371/journal.pone.0021911.g004
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have indicated that TGF-b stimulation of collagen gene expression
requires inactivation of the transcriptional repressor Fli1 through a
PKCd-dependent Fli1 phosphorylation [35], we examined the
effects of rCCN2 on Fli1 phosphorylation status. As a positive
control, cells were stimulated for 3 hours with TGF-b as
previously described [35]. Recombinant CCN2 rapidly and
potently induced Fli1 phosphorylation to a much higher level
than that observed after TGF-b stimulation (Fig. 6F). While these
results suggest that CCN2 may function as a primary inducer of p-
Fli1 in the TGF-b pathway, additional studies are required to
further investigate this interesting finding. Collectively, these
results indicate that effects of CCN2 are dose-dependent, with
the pro-fibrotic effects observed only with the low doses (in the
range of those induced by TGF-b).
Discussion
CCN2 is almost universally overexpressed during organ fibrosis
and is considered to be a key effector of the fibrogenic effects of
TGF-b. While the precise contribution of CCN2 to this process
has not been clearly defined, previous studies support the view of
cooperation between CCN2 and TGF-b in the process of
sustained fibrotic response [22,36]. In this study we focused on
characterizing the CCN2-dependent signaling pathways that are
required for the TGF-b induced fibrogenic process. By depleting
endogenous CCN2 we show that CCN2 is necessary for the TGF-
b induced phosphorylation of Smad1 and Erk1/2, but it is
dispensable for activation of the Smad3 pathway. Our study
suggests that this action of CCN2 is mediated via integrin receptor
signaling. In response to TGF-b stimulation, CCN2 forms
complexes with the avb3 integrin receptor, which triggers
activation of Src and Erk1/2 pathways, but the specific
mechanisms involved in activation of these two pathways is
presently unknown. In agreement with previous studies in
mesangial cells [20], we show that CCN2 alone activates Src
and Erk1/2 signaling. However, CCN2 is not able to phosphor-
ylate either Smad1 or Smad3. Consequently, in the absence of
TGF-b, CCN2 is only a weak inducer of collagen protein
synthesis. Together, these data suggest that activation of Smad1
pathway requires coordinated action of TGF-b and CCN2
signaling through their cognate receptors. As CCN2 has been
shown to bind TGF-b and enhance TGF-b receptor binding and
signaling [22], Smad1 and Erk1/2 pathways could be activated in
a spatially and temporally coordinated manner (Fig. 7).
This study revealed a dose-dependent effect of CCN2 on
collagen gene regulation. The stimulatory effects were only
observed at low doses of CCN2, in the range of those induced
by TGF-b, while at high doses CCN2 inhibited basal collagen
mRNA and protein expression. Furthermore, while we observed
that CCN2 is quite potent in inducing collagen mRNA levels and
collagen promoter activity, collagen protein levels were only
weakly induced. Interestingly, we observed that rCCN2 induces
rapid (5 min.) and sustained (up to 3 hours) phosphorylation of
Fli1, which constitutes a key event regulating dissociation of Fli1
from the collagen promoter [35]. CCN2-mediated dissociation of
Figure 5. CCN2 induces Src and Erk1/2 phosphorylation. (A) Foreskin fibroblasts were serum starved overnight and then stimulated with
indicated doses of recombinant CCN2 (rCCN2) (5 - 100 ng/ml) for 30 minutes and analyzed for Src and Erk1/2 phosphorylation. (B) Foreskin
fibroblasts were serum starved overnight and then stimulated with rCCN2 (25 ng/ml) for the indicated time points and analyzed for Src and Erk1/2
phosphorylation. (C) Foreskin fibroblasts were transfected with b3 siRNA oligos and then stimulated with rCCN2 for 30 minutes and examined the Src
and Erk1/2 phosphorylation by western blot. (D) Foreskin fibroblasts were treated with rCCN2 for 48 hours and then were analyzed for Smad1
expression levels by western blot.
doi:10.1371/journal.pone.0021911.g005
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upregulation of collagen genes by CCN2, however other
transcription factors, which are activated by Erk1/2 signaling
e.g. Sp1 [37] and Erg-1 [38], could also be involved. Interestingly,
however, an increase in collagen mRNA was not sufficient to result
in significant changes in collagen protein production, suggesting
that other cellular pathways, which are induced by TGF-b or
other co-stimulators such as insulin/IGF-1 [39] are required for
the significant upregulation of collagen protein by CCN2. In
contrast to its contribution to the pro-fibrotic effects of TGF-b,
CCN2 is a potent inducer of the collagen-degrading enzyme
MMP1 [18]. Furthermore, our recent studies demonstrate that
rCCN2 upregulates MMP1 gene expression through activation of
key transcriptional regulators of this gene, including Erk1/2/Ets1
and c-Jun [40]. CCN2-induced MMP1 synthesis was not dose-
sensitive and occurred at a wide range of CCN2 concentrations
(50–500 ng/ml). On the other hand, profibrotic effects of CCN2
were observed only at the lower doses of CCN2 (,50 ng/ml). This
observation adds further complexity to the molecular mechanisms
underlying diverse roles of CCN2 in matrix regulation. Together,
these data suggest that the role of CCN2 in matrix regulation is
context-dependent and its profibrotic function is fully manifested
only in the presence of TGF-b or other profibrotic mediators.
There is increasing evidence that activation of Smad1 signaling
may play a pivotal role in the process of fibrosis [41,42,43].
Consistent with this notion, blockade of Smad1 via siRNA
completely abrogated TGF-b stimulation of collagen and CCN2
in dermal fibroblasts [3]. The ability of TGF-b to activate Smad1
signaling, in addition to the conventional Smad2/3, has been
confirmed in a variety of cells; however, specific mechanisms
Figure 6. CCN2 induced up-regulation of collagen gene expression is dose dependent. (A) Foreskin fibroblasts were transduced with
increasing doses of CCN2 (5, 10, 25, 50 MOI) overexpressing virus. Collagen mRNA levels were determined by quantitative RT-PCR (A, left panel) and
collagen protein levels were determined by western blot (A, right panel). The values represent mean 6 S.E. of three independent experiments.
*, significant values at p,0.05. (B) Foreskin fibroblasts were stimulated with 2.5 ng/ml of TGF-b or transduced with AdCCN2 (10 MOI) for 48 hours.
Collagen and CCN2 protein levels were determined by western blot. (C) COL1A1 mRNA levels was determined by qPCR in foreskin fibroblasts
stimulated with TGF-b (2.5 ng/ml) or indicated doses of rhCCN2 for 24 hours. The values represent mean 6 S.E. (n=4; *, significant values at p,0.05).
(D) Foreskin fibroblasts were transfected with COL1A2 (22 Kb) luciferase promoter plasmid construct. Next day after transfection TGF-b or rCCN2
were added for 24 hours and the promoter activity was determined. The values represent mean 6 S.E. (n=4; *, significant values at at p,0.05). (E)
Foreskin fibroblasts were treated with rCCN2 at various concentrations and analyzed for collagen levels in the culture medium. (F) Foreskin fibroblasts
were treated with rCCN2 (20 ng/ml) at the indicated time periods and with TGF-b (2.5 ng/ml) for 3 hours and analyzed for phosphorylated and total
Fli1 by western blot from nuclear extracts.
doi:10.1371/journal.pone.0021911.g006
CCN2 Contributes to Smad1 Phosphorylation
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TGF-b dependent activation of Smad1 in dermal fibroblasts has
not been thoroughly investigated. Our studies suggest that Smad1
activation may involve cooperation between two TGF-b type I
receptors, ALK5 and ALK1 [3], and a co-receptor endoglin [44],
thus resembling signaling complex described in endothelial cells
[45]. In this study we show for the first time that CCN2 is also
required for the activation of the Smad1 pathway. Furthermore,
our data suggest that Src/Erk1/2 signaling plays an essential role
in this process. This finding is consistent with the previous studies
that demonstrated dependence of Smad1 activation on Src in the
Angiotensin II-dependent model of diabetic nephropathy [46] and
in lung carcinoma [47]. However, the specific role of Src in
activation of Smad1 has not been defined.
This study provides new insights into the specific role of CCN2 in
the profibrotic TGF-b signaling. We show that CCN2 is required
fortheTGF-binducedcollagenproductionbyfacilitatingactivation
of Smad1 and Erk1/2 signaling pathways. Importantly, Smad1 and
Erk1/2, as well as Ets1 were shown previously to play a key role in
activation of CCN2 gene expression [3,43,48,49]. Together these
results indicate the existence of an autocrine loop between TGF-b/
Smad1 and CCN2 pathways that regulates pro-fibrotic gene
expression in fibroblasts (Fig. 7). Shi-wen et al proposed that an
autocrine CCN2-dependent loop maintains fibrosis in scleroderma
[50] and several later studies further supported this concept. For
example, a strong correlation between collagen and CCN2
expression levels, and Smad1 activation status was observed in
hTERT immortalized scleroderma clones [51] and blockade of
Smad1 in scleroderma fibroblasts normalized collagen and CCN2
production by these cells [43]. This study provides further details on
the signaling cascade leading to activation of Smad1 in SSc
fibroblasts and suggests the involvement of Src in this process.
Consistent with our findings blockade of Src inhibited collagen
production in scleroderma fibroblasts and ameliorated dermal
fibrosis in a bleomycin mouse model [34]. Because of its association
with tissue fibrosis, CCN2 has been considered an attractive target
for anti-fibrotic therapy in SSc and other fibrotic diseases [52].
However, depending on the presence of other factors, CCN2 in
addition to having a pro-fibrotic effect, could also play an important
role in matrix remodeling. Thus, blockade of its function may only
be beneficial during selected stages of the disease. Better
understanding of the regulatory mechanisms involved in CCN2
gene expression and function should help to clarify these issues in
the future.
Figure 7. A proposed model for the positive feedback loop between TGF-b/Smad1 and CCN2 pathway. See Discussion text for details.
doi:10.1371/journal.pone.0021911.g007
CCN2 Contributes to Smad1 Phosphorylation
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Cell culture
Human fibroblasts cultures were established from the foreskins
of the newborn as described previously [49]. Regular maintenance
and propagation of the culture was carried out in DMEM
supplemented with 10% serum. All experiments were carried out
in early passage cells.
Plasmids, Transient transfections and Luciferase assay
Human collagen promoter (22 Kb) cloned upstream of
luciferase reporter gene in pGL3 vector (COL1A2 -Luc) was a
gift from A. Gabrielli, University of Ancona and was described
previously [53]. Transient transfections were performed in foreskin
fibroblasts seeded into 12 well plates using Fugene6 (Roche)
according to the manufacturer’s instructions. After overnight
incubation some cells were treated with either TGF-b (2.0 ng/ml)
or rCCN2 (5–50 ng/ml) (EMP Genetech) and then further
incubated for 24 hours. The cells were harvested and assayed
for luciferase reporter activity using Promega Luciferase assay kit
as per manufacturer’s instructions. Co-transfection with pSV-b-
galactosidase control vector was used to normalize for transfection
efficiency. b-galactosidase was measured using Galacto-Light-Plus
(Tropix).
Adenoviral siRNA vectors
Adenoviral siRNA sequence CCAAGCCTATCAAGTTTGA
targeting CCN2 was generated as described previously [49].
Annealed double stranded oligonucleotides were cloned into Mlu1
and Xho 1 sites of pRNAT-H1.1 shuttle vector (Genescript). The
shuttle vector with target siRNA sequence was linearized with
Pme1 and then electroporated into BJ5183-AD-1 (Stratagene) to
generate recombinant Adenoeasy vector. The recombinant
Adenoeasy plasmid after linearization with Pac1 enzyme was
transfected into QBI-293 cells using Transfectin (Bio-Rad) for
generation of adenovirus. The shuttle vector plasmid and
Adenoeasy vector plasmid were sequenced to confirm the cloning.
The primary adenoviral stock was then amplified and concentrat-
ed by Cesium chloride density gradient centrifugation. Control
Scrambled adenovirus vector was prepared in the same manner.
SiRNA oligos against Src [47] and b3 [54] were ordered from
Dharmacon. The oligos were transfected using HiPerfect reagent
(Qiagen) as per manufacturer’s instructions.
RNA isolation, QRT-PCR
Total RNA was isolated from the fibroblasts using Tri reagent
(MRC Inc) according to manufacturer’s instructions. 2 mg of RNA
was reverse transcribed in 20 ml reaction volume using random
primersand TranscriptorFirstStrand synthesiskit(Roche)and then
diluted to 100 ml. Real time quantitative PCR was carried out using
IQ Sybr green mix (Biorad) on Icycler machine (Biorad) using 1 ml
of the cDNA in triplicates with b-actin as the internal control. The
primers used are CCN2 - 59-TTGCGAAGCTGACCTGGAA-
GAGAA 39 (forward), 59- AGCTCGGTATGTCTTCATGC-
TGGT-39 (reverse); COL1A1 59- CCAGAAGAACTGGTACAT-
CAGCA -39 (forward), 59- CGCCATACTCGAACTGGGAAT -
39 (reverse); COL1A2 59-GATGTTGAACTTGTTGCTGAGG -
39 (forward), 59- TCTTTCCCCATTCATTTGTCTT-39 (reverse)
and have been validated to b-actin. The fold change in the levels of
genes of interest was determined by 2
2DDCt. PCR conditions were
95uC for 3 min, followed by 40 cycles of 95uC for 30 sec, 58uC for
1 min. To check for absence of secondary products a melt curve
analysis for the PCR product was carried out.
Western blotting and Immunoprecipitation
Cell lysates were prepared in RIPA buffer. 30–100 mg of protein
was separated on SDS-PAGE and then transferred on nitrocel-
lulose membrane. The membranes were blocked with 3% nonfat
dry milk in Tween/Tris buffered saline. The membranes were
then probed with antibodies against pSmad3, total Smad2/3,
pSmad1, pErk, total Erk (Cell Signaling), Total Smad1 (Santa
Cruz), and Collagen (Southern Biotechnologies). For CCN2
western blot, the membranes were blocked in 2% gelatin and
probed with anti CCN2 antibody (Santa Cruz) overnight at room
temperature. Western blotting procedure for phospho-Fli1 and
Fli1 was described previously [35]. The blots were then incubated
with appropriate horseradish peroxidase coupled secondary
antibodies and developed using Chemilumicent Kit (Pierce). For
loading control, either the blots were stripped and re-probed for b-
actin (Sigma) or separate gels were run and probed.
For immunoprecipitation experiments, cell lysates were pre-
pared in NP40 buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl,
0.02% sodium azide, 0.1% SDS, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 50 mM sodium fluoride, 0.5 mM dithiothreitol,
2 mM sodium orthovanadate, and 1 mM PMSF with protease
inhibitors (Mixture Set III, Calbiochem)) and were precleared with
Protein A/G ultralink resin (Pierce). The lysates were then
incubated with anti b3 antibody (Santa Cruz) or anti avb3
antibody (Millipore) overnight at 4uC. The immunocomplexes
were then pulled down with Protein A/G ultralink resin and
washed 46 with NP40 buffer. The beads were suspended in 26
sample loading buffer and the immunoprecipitates were eluted by
boiling for 5 min in 26 SDS sample buffer, and analyzed by
Western blot as described earlier.
Immunohistochemistry
Cells were grown on coverslips and fixed in 4% paraformalde-
hyde in PBS for 10 min. After washing with PBS, cells were
permeabilized with 0.1% Triton X-100 in PBS for 10 min at room
temperature. The samples were incubated with anti-avb3 (LM609
– Millipore) followed by anti CCN2 antibodies (Biovision) in 1%
bovine serum albumin in PBS. Anti-mouse and anti-rabbit
conjugated to AlexaFluor 488 and 546 respective secondary
antibodies (Invitrogen) were used to visualize the proteins. The
coverslips were then mounted on to glass slides and viewed with
Olympus IX70 microscope equipped with the Fluoview 300
confocal.
Statistical analysis
The student’s t-test analysis using GraphPad InStat Statistics
Software (v 1.12) was performed to determine statistical signifi-
cance. Values of less than or equal to 0.05 were considered
statistically significant.
Supporting Information
Figure S1 Graphical presentation of densitometric scans. (A)
Phosphorylation of Erk in response to TGF-b stimulation after
suppression of CCN2 as shown Figure 2B. The values represent
mean 6 S.E. (n=3, * p,0.05) (B) phosphorylation of Smad3 in
response to TGF-b stimulation after suppression of CCN2 as
shown Figure 2C. The values represent mean 6 S.E. (n=3).
(TIF)
Figure S2 avb3 integrin mediates TGF-b induced Smad1
phosphorylation (A) Foreskin fibroblasts were transfected with b3
siRNA oligos and mRNA levels of b3 integrin was measured
(n=3, * p,0.01). (B) Foreskin fibroblasts were pretreated with
CCN2 Contributes to Smad1 Phosphorylation
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e21911avb3 function blocking antibody LM609 or control IgG and then
stimulated with TGF-b for 30 minutes and analyzed for Smad1
phosphorylation.
(TIF)
Figure S3 TGF-b induced Smad1 phosphorylation is mediated
through Src (A) Foreskin fibroblasts were transfected with Src
siRNA oligos and mRNA levels of Src was measured (n=3,
*p ,0.01). (B) Foreskin fibroblasts were pretreated with Src
inhibitor SU6656 for 1 hour and then stimulated with TGF-b for
30 minutes and analyzed for Smad1 phosphorylation.
(TIF)
Figure S4 Graphical presentation of densitometric scans of
Smad1 protein levels after CCN2 stimulation as shown in
Figure 5D. The values represent mean 6 S.E. (n=3, * p,0.05)
(TIF)
Author Contributions
Conceived and designed the experiments: MT SSN AMB. Performed the
experiments: SSN AMB. Analyzed the data: MT SSN AMB. Contributed
reagents/materials/analysis tools: MT SSN AMB. Wrote the paper: MT
SSN AMB.
References
1. Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:
753–791.
2. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral
TGFbeta/ALK5 signaling. Mol Cell 12: 817–828.
3. Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M (2007)
Transforming growth factor-beta receptor type I-dependent fibrogenic gene
program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol
Chem 282: 10405–10413.
4. Wrighton KH, Lin X, Yu PB, Feng XH (2009) Transforming Growth Factor
{beta} Can Stimulate Smad1 Phosphorylation Independently of Bone
Morphogenic Protein Receptors. J Biol Chem 284: 9755–9763.
5. ten Dijke P, Goumans MJ, Pardali E (2008) Endoglin in angiogenesis and
vascular diseases. Angiogenesis 11: 79–89.
6. Liu IM, Schilling SH, Knouse KA, Choy L, Derynck R, et al. (2009) TGFbeta-
stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates
the pro-migratory TGFbeta switch. EMBO J 28: 88–98.
7. Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19:
128–139.
8. Moustakas A, Heldin CH (2008) Dynamic control of TGF-beta signaling and its
links to the cytoskeleton. FEBS Lett 582: 2051–2065.
9. Moussad EE, Brigstock DR (2000) Connective tissue growth factor: what’s in a
name? Mol Genet Metab 71: 276–292.
10. Bleau AM, Planque N, Perbal B (2005) CCN proteins and cancer: two to tango.
Front Biosci 10: 998–1009.
11. Shi-Wen X, Leask A, Abraham D (2008) Regulation and function of connective
tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine
Growth Factor Rev 19: 133–144.
12. Rachfal AW, Brigstock DR (2005) Structural and functional properties of CCN
proteins. Vitam Horm 70: 69–103.
13. Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, et al. Selective expression
of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue
fibrosis. Arthritis Rheum 62: 1523–1532.
14. Liu S, Shi-wen X, Abraham DJ, Leask A (2011) CCN2 is required for
bleomycin-induced skin fibrosis in mice. Arthritis Rheum 63: 239–246.
15. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, et al. (2007) A
polymorphism in the CTGF promoter region associated with systemic sclerosis.
N Engl J Med 357: 1210–1220.
16. Wang B, Carter RE, Jaffa MA, Nakerakanti S, Lackland D, et al. Genetic
variant in the promoter of connective tissue growth factor gene confers
susceptibility to nephropathy in type 1 diabetes. J Med Genet 47: 391–397.
17. Grotendorst GR (1997) Connective tissue growth factor: a mediator of TGF-
beta action on fibroblasts. Cytokine Growth Factor Rev 8: 171–179.
18. Chen CC, Chen N, Lau LF (2001) The angiogenic factors Cyr61 and connective
tissue growth factor induce adhesive signaling in primary human skin fibroblasts.
J Biol Chem 276: 10443–10452.
19. Babic AM, Chen CC, Lau LF (1999) Fisp12/mouse connective tissue growth
factor mediates endothelial cell adhesion and migration through integrin
alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in
vivo. Mol Cell Biol 19: 2958–2966.
20. Crean JK, Finlay D, Murphy M, Moss C, Godson C, et al. (2002) The role of
p42/44 MAPK and protein kinase B in connective tissue growth factor induced
extracellular matrix protein production, cell migration, and actin cytoskeletal
rearrangement in human mesangial cells. J Biol Chem 277: 44187–44194.
21. Wahab NA, Weston BS, Mason RM (2005) Connective tissue growth factor
CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc
Nephrol 16: 340–351.
22. Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002) Connective-tissue
growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell
Biol 4: 599–604.
23. Wenger C, Ellenrieder V, Alber B, Lacher U, Menke A, et al. (1999) Expression
and differential regulation of connective tissue growth factor in pancreatic cancer
cells. Oncogene 18: 1073–1080.
24. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, et al. (1998) Connective
tissue growth factor mRNA expression is upregulated in bleomycin-induced lung
fibrosis. Am J Physiol 275: L365–371.
25. Ricupero DA, Rishikof DC, Kuang PP, Poliks CF, Goldstein RH (1999)
Regulation of connective tissue growth factor expression by prostaglandin E(2).
Am J Physiol 277: L1165–1171.
26. Kucich U, Rosenbloom JC, Herrick DJ, Abrams WR, Hamilton AD, et al.
(2001) Signaling events required for transforming growth factor-beta stimulation
of connective tissue growth factor expression by cultured human lung fibroblasts.
Arch Biochem Biophys 395: 103–112.
27. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, et al. (1999)
Connective tissue growth factor mediates transforming growth factor beta-
induced collagen synthesis: down-regulation by cAMP. Faseb J 13: 1774–1786.
28. Yokoi H, Sugawara A, Mukoyama M, Mori K, Makino H, et al. (2001) Role of
connective tissue growth factor in profibrotic action of transforming growth
factor-beta: a potential target for preventing renal fibrosis. Am J Kidney Dis 38:
S134–138.
29. Zhang C, Meng X, Zhu Z, Yang X, Deng A (2004) Role of connective tissue
growth factor in renal tubular epithelial-myofibroblast transdifferentiation and
extracellular matrix accumulation in vitro. Life Sci 75: 367–379.
30. Quan T, Shao Y, He T, Voorhees JJ, Fisher GJ (2010) Reduced expression of
connective tissue growth factor (CTGF/CCN2) mediates collagen loss in
chronologically aged human skin. J Invest Dermatol 130: 415–424.
31. Scaffidi AK, Petrovic N, Moodley YP, Fogel-Petrovic M, Kroeger KM, et al.
(2004) alpha(v)beta(3) Integrin interacts with the transforming growth factor beta
(TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in
living human lung fibroblasts. J Biol Chem 279: 37726–37733.
32. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, et al. (2005) Increased
expression of integrin alpha(v)beta3 contributes to the establishment of autocrine
TGF-beta signaling in scleroderma fibroblasts. J Immunol 175: 7708–7718.
33. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in
normal and cancer cells. Curr Opin Cell Biol 18: 516–523.
34. Skhirtladze C, Distler O, Dees C, Akhmetshina A, Busch N, et al. (2008) Src
kinases in systemic sclerosis: central roles in fibroblast activation and in skin
fibrosis. Arthritis Rheum 58: 1475–1484.
35. Asano Y, Trojanowska M (2009) Phosphorylation of Fli1 at threonine 312 by
protein kinase C delta promotes its interaction with p300/CREB-binding
protein-associated factor and subsequent acetylation in response to transforming
growth factor beta. Mol Cell Biol 29: 1882–1894.
36. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, et al. (1999) Role
and interaction of connective tissue growth factor with transforming growth
factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 181:
153–159.
37. Tan NY, Khachigian LM (2009) Sp1 phosphorylation and its regulation of gene
transcription. Mol Cell Biol 29: 2483–2488.
38. Bhattacharyya S, Chen SJ, Wu M, Warner-Blankenship M, Ning H, et al. (2008)
Smad-independent transforming growth factor-beta regulation of early growth
response-1 and sustained expression in fibrosis: implications for scleroderma.
Am J Pathol 173: 1085–1099.
39. Gore-Hyer E, Pannu J, Smith EA, Grotendorst G, Trojanowska M (2003)
Selective stimulation of collagen synthesis in the presence of costimulatory
insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
Arthritis Rheum 48: 798–806.
40. Bujor AM, Nakerakanti S, Morris E, Hant FN, Trojanowska M (2010) Akt
inhibition up-regulates MMP1 through a CCN2-dependent pathway in human
dermal fibroblasts. Experimental Dermatology 19: 347–354.
41. Abe H, Matsubara T, Iehara N, Nagai K, Takahashi T, et al. (2004) Type IV
collagen is transcriptionally regulated by Smad1 under advanced glycation end
product (AGE) stimulation. J Biol Chem 279: 14201–14206.
42. Wiercinska E, Wickert L, Denecke B, Said HM, Hamzavi J, et al. (2006) Id1 is a
critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate
cells. Hepatology 43: 1032–1041.
43. Pannu J, Asano Y, Nakerakanti S, Smith E, Jablonska S, et al. (2008) Smad1
pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib
mesylate. Arthritis Rheum 58: 2528–2537.
44. Morris E, Chrobak I, Bujor A, Hant F, Mummery C, et al. (2011) Endoglin
promotes TGF-beta/Smad1 signaling in scleroderma fibroblasts. J Cell Physiol.
45. Lebrin F, Deckers M, Bertolino P, Ten Dijke P (2005) TGF-beta receptor
function in the endothelium. Cardiovasc Res 65: 599–608.
CCN2 Contributes to Smad1 Phosphorylation
PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e2191146. Mima A, Matsubara T, Arai H, Abe H, Nagai K, et al. (2006) Angiotensin II-
dependent Src and Smad1 signaling pathway is crucial for the development of
diabetic nephropathy. Lab Invest 86: 927–939.
47. Gautschi O, Tepper CG, Purnell PR, Izumiya Y, Evans CP, et al. (2008)
Regulation of Id1 expression by SRC: implications for targeting of the bone
morphogenetic protein pathway in cancer. Cancer Res 68: 2250–2258.
48. Leivonen SK, Hakkinen L, Liu D, Kahari VM (2005) Smad3 and extracellular
signal-regulated kinase 1/2 coordinately mediate transforming growth factor-
beta-induced expression of connective tissue growth factor in human fibroblasts.
J Invest Dermatol 124: 1162–1169.
49. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M
(2006) Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2
gene regulation and induction of the profibrotic gene program. J Biol Chem 281:
25259–25269.
50. Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, et al. (2000)
Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis
genes in systemic sclerosis. Exp Cell Res 259: 213–224.
51. Kapanadze B, Morris E, Smith E, Trojanowska M (2009) Establishment and
characterization of scleroderma fibroblast clonal cell lines by introduction of the
hTERT gene. J Cell Mol Med.
52. Abraham D (2008) Connective tissue growth factor: growth factor, matricellular
organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
Rheumatology (Oxford) 47 Suppl 5: v8–9.
53. Luchetti MM, Paroncini P, Majlingova P, Frampton J, Mucenski M, et al. (2003)
Characterization of the c-Myb-responsive region and regulation of the human
type I collagen alpha 2 chain gene by c-Myb. J Biol Chem 278: 1533–1541.
54. Smith HW, Marra P, Marshall CJ (2008) uPAR promotes formation of the
p130Cas-Crk complex to activate Rac through DOCK180. J Cell Biol 182:
777–790.
CCN2 Contributes to Smad1 Phosphorylation
PLoS ONE | www.plosone.org 11 July 2011 | Volume 6 | Issue 7 | e21911